07.09.25 -- U.S. Tariffs And Their Tenuous Impact On Clinical Trials

Strategic planning for representative clinical trials improves outcomes, regulatory alignment, recruitment efficiency, and commercial value by ensuring study populations mirror real-world patients.

The initial IRB submission process can involve common challenges. To help you overcome these obstacles, discover seven fundamentals you should know about a successful initial IRB submission.

In 2025, clinical trial operations are undergoing a transformative shift driven by the need for speed, cost-efficiency, and patient-centered approaches.

The future of psychedelic medicine depends on applying strict scientific standards, using evidence-based approaches to manage the challenges of studying these consciousness-altering compounds.

Determining a drug candidate’s probability of commercial success is a significant phase in the drug development process. There is no room for error.

In response to insufficient traditional dose-escalation methods, regulatory initiatives like the FDA’s Project Optimus advocate for identifying optimal biological doses rather than relying on MTD.

SuiteSuccess for contract and clinical research organizations (CROs) allows you to unify clinical applications to improve visibility and oversight across the organization in one software platform.

Remote cardiac monitoring technology is enabling the pharmaceutical industry to shift towards innovative, efficient, and patient-friendly clinical trials.